S A W Fadilah

Association of genotypes and haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patients

Anthony Au, Abdul Aziz Baba, Ai Sim Goh et al. · Biomedicine & Pharmacotherapy · 2014 · 61 citations

Hematological Malignancy, Engineering, Genetic Epidemiology +9

The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy

Zhe Kang Law, Hui Jan Tan, S. Chin et al. · Cytotherapy · 2021 · 61 citations

Intravenous Infusion, Thrombosis, Cardiovascular Disease +13

Panobinostat in combination with bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma: an open-label, multicentre phase 2 trial

Daryl Tan, Colin Phipps, William Ying Khee Hwang et al. · The Lancet Haematology · 2015 · 59 citations

Hematological Malignancy, Lymphoid Neoplasia, Multicentre Phase 2 +6

BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients—Frequency and clinical outcome

Marjanu Hikmah Elias, Abdul Aziz Baba, Azlan Husin et al. · Leukemia Research · 2014 · 56 citations

Hematological Malignancy, Engineering, Medicine +11

Transverse myelopathy following intrathecal administration of chemotherapy.

Hui Seong Teh, S A W Fadilah, Chooi Fun Leong · PubMed · 2007 · 35 citations

Transverse Myelopathy, Hematological Malignancy, Lymphoid Neoplasia +11